BioAro Inc. Launches Revolutionizing Healthcare AI with PanOmiQ™
BioAro Inc. unveils the world’s first large language model (LLM) powered by unified multi-omics data—The BioIntelligence™—at the Global Health Exhibition in Riyadh. This groundbreaking platform, PanOmiQ™, addresses modern medicine’s fragmentation by interpreting complex biological interactions, facilitating the understanding of diseases like cancer and diabetes. With PanOmiQ™, clinical data is processed on-premises, ensuring compliance with GDPR and HIPAA regulations while maintaining data sovereignty and eliminating cloud vulnerabilities.
The ecosystem also features tools like Genelio™, enabling personalized genomic dialogue, and is supported by the Axion™ Series of FPGA-accelerated hardware for healthcare applications. “We’re igniting a movement from reactive to proactive health,” says CEO Dr. Anmol Kapoor. BioAro positions itself as a leader in intelligent health tech, transforming data into actionable insights, advancing healthcare in the UAE and beyond. For more details, visit PanOmiQ.com.
